Two lots of Teva-Pregabalin 150 mg capsules recalled due to cross-contamination with the drug sertralineConsumer ProductsAug 15th, 2026 @ 12:00 PM
Basic Details
Category: Health products - Drugs
Product: Teva-Pregabalin 150 mg capsules
Issue: Health products - Contamination
What to do: If you experience a serious allergic reaction (anaphylaxis), stop taking the affected product and seek immediate medical help by calling 9-1-1. Otherwise, do not stop taking your pregabalin medication without first speaking with your healthcare professional or pharmacist, as stopping suddenly may cause withdrawal symptoms. Return the product to the pharmacy where it was purchased as soon as possible for a replacement or alternative supply, and for proper disposal. If you are unsure whether your product is recalled, check with your pharmacy.
Distribution: National
National
Products
| Product | DIN | Lot | Expiry |
|---|---|---|---|
| Teva-Pregabalin 150 mg capsules | 02361205 | 100070495100068913 | July 31, 2027 |
Recall Monitor
Information presented from Recalls and Safety Alerts dataset, provided by the Government of Canada through the Open Government initiative and is subject to the Open Government License.
You can access this data free of charge via Recall Monitor, or through the Healthy Canadians website.
Get personalized SMS or Email notifications about recall alerts that matter by subscribing to Recall Monitor.
Recall Monitor is not endorsed by, or is an official product of the Government of Canada.
Made with in Vancouver, BC
© Mad Filaments Software Inc.